BICALUTAMIDE MONOTHERAPY COMPARED WITH CASTRATION IN PATIENTS WITH NONMETASTATIC LOCALLY ADVANCED PROSTATE CANCER: 6.3 YEARS OF FOLLOWUP

2000345 citationsJournal Article

Authors

Peter Iversen · Rigshospitalet

C. Tyrrell · The Royal Free Hospital

Amir V. Kaisary · Tampere University

John Anderson · The Royal Free Hospital

Hendrik Van Poppel · KU Leuven

Teuvo L.J. Tammela · University of Copenhagen

M. C. Chamberlain ·

Abstract

Monotherapy with 150 mg. bicalutamide is an attractive alternative to castration in patients with locally advanced prostate cancer for whom immediate hormone therapy is indicated.

Topics & Keywords

Prostate Cancer Treatment and Research Hormonal and reproductive studies Statistical Methods in Clinical Trials

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: The Journal of Urology

Volume 164, Issue 5, pp. 1579-1582

DOI: 10.1016/s0022-5347(05)67032-2

Field-Weighted Citation Impact: 21.97